RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
2.6
4.52
|
| Price Target |
|
We'll email you a reminder when the closing price reaches TRY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| TR |
|
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
IST:RTALB.E
|
1.9B TRY |
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
393.1B USD |
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
185.9B USD |
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.7B USD |
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
120.7B USD |
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.5B USD |
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
86.9B AUD |
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.4B EUR |
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Market Distribution
| Min | -16 384.1% |
| 30th Percentile | 1% |
| Median | 6.4% |
| 70th Percentile | 15.5% |
| Max | 944% |
Other Profitability Ratios
RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS
Glance View
RTA Laboratuvarlari Biyolojik Ürünler Ilaç ve Makine Sanayi Ticaret AS engages in the production, research, and development in vitro diagnostics. Its diagnostic products include: Clinical Microbiology, such as chromogenic media, culture media in petri dishes, tubes and bottles, rodac petri surcheck, and tuberculosis diagnosis products; ELISA Kits, such as HBsAg ELISA Kit; Molecular Diagnostics, such as nucleic acid isolation kits, real-time PCR instruments, real-time PCR kits and RTA VOLTRAN voral detection system, as well as other tests. Its Research includes: dehydrated culture media, such as dehydrated chromogenic culture media; nucleic acid isolation kits and real-time PCR.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS is -34.9%, which is above its 3-year median of -39.4%.
Over the last 3 years, RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret AS’s Operating Margin has decreased from 19.1% to -34.9%. During this period, it reached a low of -103.1% on Sep 30, 2023 and a high of 19.1% on May 30, 2022.